Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Surg Res. 2014 Feb 19;190(1):203–209. doi: 10.1016/j.jss.2014.02.018

Fig. 5.

Fig. 5

The effect of SIAH2 expression on the Kaplan-Meier survival curve for (A) relapse-free survival and (B) overall survival in patients with ER-positive breast cancer treated with tamoxifen. The lower quartile (25%) of SIAH2 expression in patients with ER-positive breast cancer treated with tamoxifen had a poorer relapse-free survival as compared with patients with high SIAH2 expression (the rest of 75%) (P < 0.05). Overall survival, however, did not reach statistical significance (P = 0.33).